Nov 09, 2021 9:15am EST Vyant Bio Announces Investor Conference Call and Webcast for the Third Quarter 2021
Aug 19, 2021 9:27am EDT Vyant Bio and Cyclica Announce a Strategic Collaboration to Identify Compounds to Treat CDKL5 Deficiency Disorder
Aug 16, 2021 4:01pm EDT Vyant Bio Reports Second Quarter 2021 Results and Provides Strategic Business Updates
Aug 11, 2021 9:00am EDT Vyant Bio Announces Investor Conference Call and Webcast for Second Quarter 2021
Jul 13, 2021 8:20am EDT Vyant Bio Announces Issuance of Key Patent for High-Throughput Optical Assay of Human Mixed Cell Population Spheroids
